What is the Alembic Pharmaceuticals Ltd share price today?

The share price of NSE:APLLTD-EQ on 01 Oct 2026 (as of 15:03:03 IST) is ₹815.

What is the NSE:APLLTD-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:APLLTD-EQ 52 week high low range shows a high of ₹998 and a low of ₹635.8.

What is the Alembic Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Alembic Pharmaceuticals Ltd market cap is ₹162400000000.

What is the shareholding pattern of Alembic Pharmaceuticals Ltd Stock?

The shareholding pattern of Alembic Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 69.87% Foreign Institutional Investors (FII): 4.17% Domestic Institutional Investors (DII): 7.2% Mutual Funds: 8.73% Retail & Others: 10.03% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Alembic Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Alembic Pharmaceuticals Ltd is 23.4192, and the Price-to-Book (PB) ratio is 2.2924, as on 01 Oct 2026.

Alembic Pharmaceuticals Share Price

820.40+17.60 (+2.19%)

-11.23% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+2.19%

1 Week

+2.83%

1 Month

-1.31%

3 Month

-1.68%

6 Month

+4.24%

YTD

-3.04%

1 Year

-11.23%

5 Year

+6.11%

10 Year

+21.41%

Max

+1453.79%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

803.65

786.50

748.25

706.90

635.79

High

824.40

840.30

876.40

998.00

About

Alembic Pharmaceuticals Limited is involved in manufacturing and marketing of India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities. Headquartered in Vadodara, Gujarat. It is the flagship Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

APLLTDNSE

LTP

1W Low

1W High

Market cap (₹)

1783.9+6.2 (0.35%)

1722

1796.60

4,25,150Cr

9990+210 (2.15%)

9863

10067

2,66,265Cr

4640.4+27 (0.59%)

4553

4675

1,76,301Cr

2314.5-91 (-3.78%)

2252.40

2441.90

1,25,352Cr

1255.2+9.7 (0.78%)

1217.20

1262.50

1,23,591Cr

1370.1+18.1 (1.34%)

1336.70

1376.70

1,14,351Cr

1389.6+10.7 (0.78%)

1364.60

1400.80

1,12,474Cr

2491.3-1.5 (-0.06%)

2457.90

2512.30

1,02,315Cr

1695.4+14 (0.83%)

1656.20

1708.80

97,757Cr

2026.1+15.1 (0.75%)

1988.90

2062.10

92,007Cr

818.5+20.65 (2.59%)

786.50

824.40

15,808Cr

Alembic Pharmaceuticals Share Price

820.40+17.60 (+2.19%)

-11.23% past 1 Year

Financial overview

Compounded Sales Growth

10 years9%

5 years6%

3 years9%

Last year10%

Compounded Profit Growth

10 years-1%

5 years-10%

3 years25%

Last year15%

Stock Price CAGR

10 years2%

5 years1%

3 years3%

1 year-13%

Return on Equity

10 years18%

5 years11%

3 years12%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
9%	6%	9%	10%
-1%	-10%	25%	15%
2%	1%	3%	-13%
18%	11%	12%	12%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

APLLTD

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,783.9	₹425150 Cr	38.77	8.29	58.23	₹11479 Cr
9,990	₹266265 Cr	91.03	34.04	128.41	₹2568 Cr
4,640.4	₹176301 Cr	83	14.04	106.21	₹2163 Cr
2,314.5	₹125352 Cr	93.56	8.17	33.94	₹889 Cr
1,255.2	₹123591 Cr	27.39	9.42	62.53	₹5040 Cr
1,370.1	₹114351 Cr	40.84	11.08	59.2	₹4196 Cr
1,389.6	₹112474 Cr	38.82	10.86	52.6	₹3879 Cr
2,491.3	₹102315 Cr	45.62	17.23	76.26	₹1913 Cr
1,695.4	₹97757 Cr	26.33	17.95	96.84	₹3505 Cr
2,026.1	₹92007 Cr	16.64	30.95	154.35	₹5333 Cr
818.5	₹15808 Cr	22.8	8.81	52.7	₹675 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014	Mar 2014	Dec 2013	Sep 2013	Jun 2013	Mar 2013	Dec 2012	Sep 2012
₹2150 Cr	₹1848 Cr	₹1876 Cr	₹1910 Cr	₹1711 Cr	₹1770 Cr	₹1693 Cr	₹1648 Cr	₹1562 Cr	₹1517 Cr	₹1631 Cr	₹1595 Cr	₹1486 Cr	₹1406 Cr	₹1509 Cr	₹1475 Cr	₹1262 Cr	₹1416 Cr	₹1272 Cr	₹1292 Cr	₹1326 Cr	₹1280 Cr	₹1314 Cr	₹1457 Cr	₹1341 Cr	₹1207 Cr	₹1209 Cr	₹1241 Cr	₹949 Cr	₹927 Cr	₹1018 Cr	₹1127 Cr	₹863 Cr	₹853 Cr	₹840 Cr	₹789 Cr	₹648 Cr	₹741 Cr	₹777 Cr	₹879 Cr	₹737 Cr	₹627 Cr	₹916 Cr	₹1004 Cr	₹583 Cr	₹503 Cr	₹512 Cr	₹547 Cr	₹494 Cr	₹464 Cr	₹486 Cr	₹486 Cr	₹427 Cr	₹378 Cr	₹369 Cr	₹407 Cr
₹15 Cr	₹26 Cr	₹16 Cr	₹7 Cr	₹7 Cr	₹14 Cr	₹10 Cr	₹17 Cr	₹2 Cr	₹4 Cr	₹3 Cr	₹10 Cr	₹12 Cr	₹89 L	₹44 L	₹33 L	₹1 Cr	₹10 Cr	₹15 Cr	₹2 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹32 L	₹89 L	₹41 L	₹36 L	₹3 Cr	₹3 Cr	₹4 Cr	₹2 Cr	₹10 L	₹64 L	₹33 L	₹8 Cr	₹17 L	₹45 L	₹35 L	₹63 L	₹60 L	₹3 Cr	₹3 Cr	₹5 L	₹3 L	₹2 Cr	₹31 L	₹14 L	₹18 L	₹3 Cr	₹20 L	₹20 L	₹2 L	₹7 L	₹3 Cr	₹22 L
₹2165 Cr	₹1873 Cr	₹1892 Cr	₹1917 Cr	₹1717 Cr	₹1784 Cr	₹1702 Cr	₹1665 Cr	₹1564 Cr	₹1521 Cr	₹1633 Cr	₹1605 Cr	₹1498 Cr	₹1407 Cr	₹1509 Cr	₹1475 Cr	₹1263 Cr	₹1426 Cr	₹1287 Cr	₹1295 Cr	₹1330 Cr	₹1284 Cr	₹1317 Cr	₹1460 Cr	₹1342 Cr	₹1208 Cr	₹1210 Cr	₹1241 Cr	₹952 Cr	₹930 Cr	₹1022 Cr	₹1129 Cr	₹863 Cr	₹854 Cr	₹840 Cr	₹797 Cr	₹648 Cr	₹742 Cr	₹777 Cr	₹880 Cr	₹737 Cr	₹630 Cr	₹919 Cr	₹1004 Cr	₹583 Cr	₹505 Cr	₹512 Cr	₹547 Cr	₹494 Cr	₹467 Cr	₹486 Cr	₹487 Cr	₹427 Cr	₹378 Cr	₹373 Cr	₹407 Cr
₹1916 Cr	₹1708 Cr	₹1663 Cr	₹1671 Cr	₹1503 Cr	₹1567 Cr	₹1503 Cr	₹1479 Cr	₹1394 Cr	₹1326 Cr	₹1434 Cr	₹1454 Cr	₹1354 Cr	₹1268 Cr	₹1327 Cr	₹1310 Cr	₹1315 Cr	₹1379 Cr	₹1086 Cr	₹1090 Cr	₹1145 Cr	₹990 Cr	₹996 Cr	₹1057 Cr	₹975 Cr	₹923 Cr	₹926 Cr	₹931 Cr	₹759 Cr	₹779 Cr	₹805 Cr	₹853 Cr	₹739 Cr	₹712 Cr	₹679 Cr	₹636 Cr	₹569 Cr	₹628 Cr	₹653 Cr	₹722 Cr	₹599 Cr	₹508 Cr	₹554 Cr	₹642 Cr	₹491 Cr	₹416 Cr	₹422 Cr	₹450 Cr	₹409 Cr	₹384 Cr	₹394 Cr	₹404 Cr	₹365 Cr	₹321 Cr	₹309 Cr	₹351 Cr
₹347 Cr	₹253 Cr	₹309 Cr	₹323 Cr	₹288 Cr	₹286 Cr	₹270 Cr	₹256 Cr	₹239 Cr	₹264 Cr	₹269 Cr	₹218 Cr	₹210 Cr	₹213 Cr	₹249 Cr	₹233 Cr	₹16 Cr	₹170 Cr	₹257 Cr	₹259 Cr	₹238 Cr	₹346 Cr	₹368 Cr	₹447 Cr	₹408 Cr	₹328 Cr	₹325 Cr	₹346 Cr	₹228 Cr	₹181 Cr	₹246 Cr	₹305 Cr	₹151 Cr	₹174 Cr	₹188 Cr	₹187 Cr	₹102 Cr	₹136 Cr	₹146 Cr	₹178 Cr	₹158 Cr	₹146 Cr	₹387 Cr	₹376 Cr	₹104 Cr	₹100 Cr	₹102 Cr	₹108 Cr	₹96 Cr	₹94 Cr	₹102 Cr	₹93 Cr	₹72 Cr	₹66 Cr	₹73 Cr	₹65 Cr
₹28 Cr	₹23 Cr	₹23 Cr	₹24 Cr	₹24 Cr	₹25 Cr	₹22 Cr	₹19 Cr	₹13 Cr	₹11 Cr	₹15 Cr	₹16 Cr	₹14 Cr	₹14 Cr	₹15 Cr	₹12 Cr	₹9 Cr	₹7 Cr	₹4 Cr	₹5 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹7 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹2 Cr	₹1 Cr	₹82 L	₹35 L	₹89 L	₹2 Cr	₹95 L	₹1 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹73 L	₹62 L	₹36 L	₹0	₹1 Cr	₹56 L	₹2 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹4 Cr	₹3 Cr
₹221 Cr	₹118 Cr	₹163 Cr	₹222 Cr	₹191 Cr	₹193 Cr	₹177 Cr	₹180 Cr	₹157 Cr	₹183 Cr	₹185 Cr	₹135 Cr	₹130 Cr	₹125 Cr	₹168 Cr	₹153 Cr	-₹60 Cr	₹41 Cr	₹197 Cr	₹200 Cr	₹183 Cr	₹292 Cr	₹318 Cr	₹398 Cr	₹360 Cr	₹266 Cr	₹276 Cr	₹303 Cr	₹155 Cr	₹146 Cr	₹211 Cr	₹270 Cr	₹122 Cr	₹141 Cr	₹161 Cr	₹161 Cr	₹79 Cr	₹112 Cr	₹124 Cr	₹157 Cr	₹137 Cr	₹120 Cr	₹364 Cr	₹362 Cr	₹91 Cr	₹88 Cr	₹90 Cr	₹96 Cr	₹85 Cr	₹81 Cr	₹89 Cr	₹80 Cr	₹61 Cr	₹55 Cr	₹60 Cr	₹53 Cr
₹172 Cr	₹200 Cr	₹134 Cr	₹182 Cr	₹154 Cr	₹157 Cr	₹137 Cr	₹152 Cr	₹134 Cr	₹179 Cr	₹181 Cr	₹137 Cr	₹121 Cr	₹161 Cr	₹136 Cr	₹135 Cr	-₹59 Cr	₹34 Cr	₹168 Cr	₹161 Cr	₹148 Cr	₹237 Cr	₹259 Cr	₹325 Cr	₹293 Cr	₹204 Cr	₹228 Cr	₹250 Cr	₹119 Cr	₹131 Cr	₹171 Cr	₹200 Cr	₹90 Cr	₹102 Cr	₹131 Cr	₹124 Cr	₹63 Cr	₹95 Cr	₹84 Cr	₹124 Cr	₹104 Cr	₹91 Cr	₹269 Cr	₹288 Cr	₹72 Cr	₹70 Cr	₹71 Cr	₹77 Cr	₹65 Cr	₹61 Cr	₹66 Cr	₹62 Cr	₹47 Cr	₹44 Cr	₹48 Cr	₹42 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹39 Cr	₹39 Cr	₹39 Cr	₹39 Cr	₹39 Cr	₹39 Cr	₹38 Cr	₹38 Cr	₹38 Cr	₹38 Cr	₹38 Cr	₹38 Cr	₹38 Cr	₹38 Cr	₹38 Cr	₹11 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹27 Cr
₹5636 Cr	₹5152 Cr	₹4779 Cr	₹4331 Cr	₹5198 Cr	₹5028 Cr	₹3182 Cr	₹2681 Cr	₹2182 Cr	₹1865 Cr	₹1560 Cr	₹847 Cr	₹638 Cr	₹465 Cr	₹357 Cr	₹259 Cr
₹5636 Cr	₹5152 Cr	₹4779 Cr	₹4331 Cr	₹5198 Cr	₹5028 Cr	₹3182 Cr	₹2681 Cr	₹2182 Cr	₹1865 Cr	₹1560 Cr	₹847 Cr	₹638 Cr	₹465 Cr	₹357 Cr	₹259 Cr
₹5675 Cr	₹5191 Cr	₹4818 Cr	₹4370 Cr	₹5238 Cr	₹5067 Cr	₹3219 Cr	₹2719 Cr	₹2220 Cr	₹1902 Cr	₹1597 Cr	₹885 Cr	₹676 Cr	₹503 Cr	₹395 Cr	₹297 Cr
-₹6 Cr	-₹1 Cr	₹0	₹0	₹0	₹0	-₹29 Cr	-₹79 L	₹31 L	₹11 L	₹0	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹19 Cr	₹42 Cr	₹60 Cr	₹76 Cr	₹90 Cr
₹122 Cr	₹0	₹0	₹0	₹0	₹200 Cr	₹887 Cr	₹499 Cr	₹500 Cr	₹0	₹0	₹0	₹10 Cr	₹11 Cr	₹19 Cr	₹39 Cr
-₹270 Cr	-₹166 Cr	-₹170 Cr	-₹123 Cr	-₹6 Cr	₹4 Cr	₹12 Cr	₹19 Cr	₹35 Cr	₹37 Cr	₹43 Cr	₹31 Cr	₹23 Cr	₹14 Cr	₹10 Cr	₹5 Cr
₹225 Cr	₹47 Cr	₹63 Cr	₹69 Cr	₹72 Cr	₹72 Cr	₹73 Cr	₹0	₹0	₹0	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹12 Cr	₹12 Cr
₹153 Cr	₹124 Cr	₹110 Cr	₹106 Cr	₹96 Cr	₹86 Cr	₹75 Cr	₹52 Cr	₹41 Cr	₹57 Cr	₹28 Cr	₹9 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹5 Cr
₹230 Cr	₹5 Cr	₹3 Cr	₹52 Cr	₹162 Cr	₹361 Cr	₹1047 Cr	₹570 Cr	₹576 Cr	₹94 Cr	₹84 Cr	₹72 Cr	₹94 Cr	₹103 Cr	₹122 Cr	₹151 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹835 Cr	₹880 Cr	₹736 Cr	₹680 Cr	₹706 Cr	₹669 Cr	₹626 Cr	₹644 Cr	₹759 Cr	₹501 Cr	₹566 Cr	₹325 Cr	₹288 Cr	₹240 Cr	₹209 Cr	₹139 Cr
₹394 Cr	₹232 Cr	₹224 Cr	₹251 Cr	₹517 Cr	₹558 Cr	₹227 Cr	₹380 Cr	₹143 Cr	₹81 Cr	₹52 Cr	₹45 Cr	₹61 Cr	₹69 Cr	₹152 Cr	₹85 Cr
₹1219 Cr	₹1196 Cr	₹430 Cr	₹636 Cr	₹430 Cr	₹2 L	₹861 Cr	₹429 Cr	₹208 Cr	₹89 Cr	₹114 Cr	₹220 Cr	₹25 Cr	₹70 Cr	₹138 Cr	₹146 Cr
₹239 Cr	₹207 Cr	₹131 Cr	₹74 Cr	₹178 Cr	₹307 Cr	₹241 Cr	₹210 Cr	₹157 Cr	₹143 Cr	₹213 Cr	₹319 Cr	₹228 Cr	₹149 Cr	₹84 Cr	₹44 Cr
₹2687 Cr	₹2514 Cr	₹1520 Cr	₹1641 Cr	₹1831 Cr	₹1533 Cr	₹1954 Cr	₹1664 Cr	₹1267 Cr	₹814 Cr	₹944 Cr	₹908 Cr	₹603 Cr	₹529 Cr	₹583 Cr	₹413 Cr
₹8586 Cr	₹7709 Cr	₹6341 Cr	₹6064 Cr	₹7230 Cr	₹6961 Cr	₹6192 Cr	₹4952 Cr	₹4064 Cr	₹2811 Cr	₹2626 Cr	₹1865 Cr	₹1372 Cr	₹1135 Cr	₹1100 Cr	₹861 Cr
₹160 Cr	₹69 Cr	₹55 Cr	₹109 Cr	₹63 Cr	₹100 Cr	₹118 Cr	₹104 Cr	₹94 Cr	₹82 Cr	₹109 Cr	₹105 Cr	₹57 Cr	₹0	₹0	₹0
₹1361 Cr	₹1196 Cr	₹430 Cr	₹636 Cr	₹630 Cr	₹500 Cr	₹1747 Cr	₹1128 Cr	₹708 Cr	₹89 Cr	₹114 Cr	₹263 Cr	₹109 Cr	₹187 Cr	₹353 Cr	₹328 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹4897 Cr	₹4117 Cr	₹3875 Cr	₹3468 Cr	₹2840 Cr	₹2545 Cr	₹2132 Cr	₹1523 Cr	₹1242 Cr	₹950 Cr	₹1094 Cr	₹861 Cr	₹665 Cr	₹572 Cr	₹463 Cr	₹434 Cr
₹1816 Cr	₹1594 Cr	₹1329 Cr	₹1069 Cr	₹1042 Cr	₹757 Cr	₹581 Cr	₹364 Cr	₹249 Cr	₹151 Cr	₹386 Cr	₹314 Cr	₹268 Cr	₹228 Cr	₹195 Cr	₹162 Cr
₹3081 Cr	₹2524 Cr	₹2547 Cr	₹2398 Cr	₹1798 Cr	₹1788 Cr	₹1552 Cr	₹1158 Cr	₹993 Cr	₹799 Cr	₹708 Cr	₹547 Cr	₹397 Cr	₹344 Cr	₹268 Cr	₹272 Cr
₹634 Cr	₹837 Cr	₹524 Cr	₹601 Cr	₹2206 Cr	₹1944 Cr	₹1574 Cr	₹1341 Cr	₹911 Cr	₹369 Cr	₹93 Cr	₹83 Cr	₹21 Cr	₹32 Cr	₹58 Cr	₹27 Cr
₹141 Cr	₹127 Cr	₹93 Cr	₹96 Cr	₹118 Cr	₹49 Cr	₹18 Cr	₹49 Cr	₹42 Cr	₹50 Cr	₹53 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr
₹141 Cr	₹127 Cr	₹93 Cr	₹96 Cr	₹118 Cr	₹49 Cr	₹18 Cr	₹49 Cr	₹42 Cr	₹50 Cr	₹53 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr
₹15 Cr	₹31 Cr	₹33 Cr	₹54 Cr	₹35 Cr	₹37 Cr	₹111 Cr	₹62 Cr	₹71 Cr	₹71 Cr	₹30 Cr	₹118 Cr	₹95 Cr	₹36 Cr	₹35 Cr	₹7 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹33 Cr	₹0	₹0	₹0	₹0	₹0
₹3920 Cr	₹3519 Cr	₹3197 Cr	₹3150 Cr	₹4255 Cr	₹4057 Cr	₹3526 Cr	₹2820 Cr	₹2116 Cr	₹1317 Cr	₹917 Cr	₹750 Cr	₹516 Cr	₹416 Cr	₹364 Cr	₹308 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹0	₹187 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹2511 Cr	₹2288 Cr	₹1644 Cr	₹1475 Cr	₹1610 Cr	₹1486 Cr	₹1188 Cr	₹967 Cr	₹734 Cr	₹633 Cr	₹570 Cr	₹383 Cr	₹311 Cr	₹267 Cr	₹259 Cr	₹219 Cr
₹1466 Cr	₹1400 Cr	₹1025 Cr	₹1046 Cr	₹807 Cr	₹349 Cr	₹865 Cr	₹489 Cr	₹526 Cr	₹339 Cr	₹350 Cr	₹361 Cr	₹273 Cr	₹233 Cr	₹199 Cr	₹202 Cr
₹203 Cr	₹90 Cr	₹127 Cr	₹82 Cr	₹69 Cr	₹106 Cr	₹81 Cr	₹206 Cr	₹90 Cr	₹160 Cr	₹451 Cr	₹27 Cr	₹24 Cr	₹16 Cr	₹47 Cr	₹6 Cr
₹81 Cr	₹69 Cr	₹60 Cr	₹55 Cr	₹52 Cr	₹79 Cr	₹28 Cr	₹18 Cr	₹27 Cr	₹8 Cr	₹7 Cr	₹0	₹0	₹0	₹0	₹0
₹375 Cr	₹343 Cr	₹289 Cr	₹255 Cr	₹437 Cr	₹698 Cr	₹504 Cr	₹452 Cr	₹570 Cr	₹355 Cr	₹330 Cr	₹344 Cr	₹248 Cr	₹203 Cr	₹231 Cr	₹125 Cr
₹4636 Cr	₹4190 Cr	₹3144 Cr	₹2914 Cr	₹2975 Cr	₹2904 Cr	₹2665 Cr	₹2132 Cr	₹1948 Cr	₹1494 Cr	₹1708 Cr	₹1115 Cr	₹857 Cr	₹719 Cr	₹736 Cr	₹553 Cr
₹1949 Cr	₹1675 Cr	₹1624 Cr	₹1273 Cr	₹1144 Cr	₹1371 Cr	₹711 Cr	₹468 Cr	₹680 Cr	₹680 Cr	₹764 Cr	₹207 Cr	₹254 Cr	₹191 Cr	₹153 Cr	₹139 Cr
₹8586 Cr	₹7709 Cr	₹6341 Cr	₹6064 Cr	₹7230 Cr	₹6961 Cr	₹6192 Cr	₹4952 Cr	₹4064 Cr	₹2811 Cr	₹2626 Cr	₹1865 Cr	₹1372 Cr	₹1135 Cr	₹1100 Cr	₹861 Cr
₹289	₹264	₹245	₹222	₹266	₹258	₹171	₹144	₹118	₹101	₹85	₹47	₹36	₹27	₹21	₹49
₹289	₹264	₹245	₹222	₹266	₹258	₹171	₹144	₹118	₹101	₹85	₹47	₹36	₹27	₹21	₹49

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
₹694 Cr	₹707 Cr	₹632 Cr	₹355 Cr	₹625 Cr	₹1368 Cr	₹1000 Cr	₹749 Cr	₹541 Cr	₹529 Cr	₹936 Cr	₹359 Cr	₹311 Cr	₹206 Cr	₹161 Cr	₹107 Cr
₹449 Cr	₹374 Cr	₹287 Cr	₹488 Cr	₹418 Cr	₹102 Cr	₹278 Cr	₹118 Cr	₹87 Cr	₹83 Cr	₹70 Cr	₹45 Cr	₹70 Cr	₹53 Cr	₹75 Cr	₹55 Cr
-₹257 Cr	-₹921 Cr	-₹96 Cr	-₹58 Cr	-₹367 Cr	₹238 Cr	-₹593 Cr	₹112 Cr	-₹181 Cr	-₹166 Cr	₹139 Cr	-₹163 Cr	-₹72 Cr	₹44 Cr	-₹62 Cr	-₹49 Cr
₹886 Cr	₹159 Cr	₹823 Cr	₹785 Cr	₹676 Cr	₹1709 Cr	₹685 Cr	₹978 Cr	₹448 Cr	₹447 Cr	₹1145 Cr	₹241 Cr	₹309 Cr	₹304 Cr	₹174 Cr	₹113 Cr
₹783 Cr	₹88 Cr	₹803 Cr	₹724 Cr	₹552 Cr	₹1463 Cr	₹449 Cr	₹812 Cr	₹312 Cr	₹329 Cr	₹948 Cr	₹172 Cr	₹240 Cr	₹265 Cr	₹142 Cr	₹95 Cr
-₹506 Cr	-₹568 Cr	-₹321 Cr	-₹448 Cr	-₹372 Cr	-₹839 Cr	-₹732 Cr	-₹756 Cr	-₹884 Cr	-₹486 Cr	-₹307 Cr	-₹256 Cr	-₹81 Cr	-₹67 Cr	-₹56 Cr	-₹57 Cr
-₹164 Cr	₹444 Cr	-₹438 Cr	-₹262 Cr	-₹217 Cr	-₹597 Cr	₹155 Cr	₹59 Cr	₹503 Cr	-₹129 Cr	-₹224 Cr	₹87 Cr	-₹151 Cr	-₹229 Cr	-₹45 Cr	-₹47 Cr
₹113 Cr	-₹37 Cr	₹45 Cr	₹14 Cr	-₹37 Cr	₹27 Cr	-₹128 Cr	₹115 Cr	-₹69 Cr	-₹286 Cr	₹417 Cr	₹3 Cr	₹8 Cr	-₹31 Cr	₹41 Cr	-₹9 Cr
₹83 Cr	₹120 Cr	₹75 Cr	₹61 Cr	₹98 Cr	₹72 Cr	₹199 Cr	₹84 Cr	₹153 Cr	₹439 Cr	₹23 Cr	₹24 Cr	₹16 Cr	₹47 Cr	₹6 Cr	₹15 Cr
₹0	₹0	₹0	₹0	₹0	-₹93 L	₹41 L	-₹7 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹196 Cr	₹83 Cr	₹120 Cr	₹75 Cr	₹61 Cr	₹98 Cr	₹72 Cr	₹199 Cr	₹84 Cr	₹153 Cr	₹439 Cr	₹27 Cr	₹24 Cr	₹16 Cr	₹47 Cr	₹6 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Alembic Pharmaceuticals Share Price

820.40+17.60 (+2.19%)

-11.23% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 4

Bearish signals: 5 out of 9 oscillators

RSI

58.70Buy

STOCH %K

94.75Sell

MACD Level(12,26)

-4.46Sell

Ultimate Oscillator

63.42Buy

Aroon Oscillator

-30.00Sell

BOP

0.60Buy

CCI

136.52Sell

Williams %R

-5.25Sell

Momentum

27.95Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 9

Bearish signals: 0 out of 9 moving averages

EMA 9

797.88Buy

SMA 9

788.34Buy

EMA 21

799.06Buy

SMA 21

794.55Buy

EMA 50

806.63Buy

SMA 50

813.90Buy

EMA 200

811.76Buy

SMA 200

777.73Buy

WMA 20

791.18Buy

Pivot

Classic

Resistance 5

870.78

Resistance 4

854.43

Resistance 3

838.08

Resistance 2

821.73

Resistance 1

812.27

Pivot

805.38

Support 1

795.92

Support 2

789.03

Support 3

772.68

Support 4

756.33

Support 5

739.98

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

803.65

786.50

748.25

706.90

635.80

635.79

635.80

462.30

414.40

31.00

High

824.40

840.30

876.40

998.00

1303.90

Returns

+17.60

+22.55

-10.85

-14.05

+33.35

-25.75

-103.80

+92.95

+47.25

+144.70

+767.60

Beta

—

Std. deviation %

—

Open a free Demat account in minutes to start investing and screening .

Alembic Pharmaceuticals Share Price

820.40+17.60 (+2.19%)

-11.23% past 1 Year

Shareholding summary

Promoters

69.87%

FII

4.55%

DII

6.94%

8.5%

Others

10.14%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
69.87%	69.87%	69.74%	69.74%	69.74%	69.67%
4.55%	4.17%	4.26%	4.23%	4.05%	3.96%
6.94%	7.20%	7.99%	7.95%	7.75%	7.41%
8.50%	8.73%	8.18%	8.22%	8.55%	9.05%
10.14%	10.03%	9.83%	9.86%	9.91%	9.91%

Bulk & block deals

Name

Ishares Core Msci Emerging Markets Etf

Ishares India Sc Mauritius Company

Ishares Core Emerging Markets Mauritius Co

Ishares Msci India Small-Cap Etf

Ishares India Sc Mauritius Company

Ishares Core Msci Emerging Markets Etf

Ishares Core Emerging Markets Mauritius Co

Ishares India Sc Mauritius Company

Ishares Core Emerging Markets Mauritius Co

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
11 Oct 2022	Purchase	11.26 Cr	₹611.25	1.84 L	Block	0.093736	BSE
11 Oct 2022	Sell	1.58 Cr	₹611.25	25.90 K	Block	0.013178	BSE
11 Oct 2022	Sell	11.26 Cr	₹611.25	1.84 L	Block	0.093736	BSE
11 Oct 2022	Purchase	1.58 Cr	₹611.25	25.90 K	Block	0.013178	BSE
03 Oct 2022	Purchase	1.52 Cr	₹604.65	25.15 K	Block	0.012795	NSE
03 Oct 2022	Sell	1.52 Cr	₹604.65	25.15 K	Block	0.012795	NSE
03 Oct 2022	Purchase	10.82 Cr	₹604.65	1.79 L	Block	0.091018	NSE
03 Oct 2022	Sell	10.82 Cr	₹604.65	1.79 L	Block	0.091018	NSE
19 Sep 2022	Sell	1.67 Cr	₹609.90	27.36 K	Block	0.013921	BSE
19 Sep 2022	Sell	11.87 Cr	₹609.90	1.95 L	Block	0.099023	BSE

Insider trading & SAST

Client name

Nirayu Private Limited

Chirayu Ramanbhai Amin Huf

Nirayu Private Limited

Chirayu Ramanbhai Amin Huf

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
19 Jun 2026	Promoter Group	Acquisition	0.001668	35.78	24.37 L	₹743.49	3.28 K	18 Jun 2026	Market Purchase	7,03,31,810	Insider Trading	—	Equity Shares
18 Jun 2026	Promoter Group	Acquisition	0.012633	35.78	1.85 Cr	₹746.34	24.83 K	16 Jun 2026 - 17 Jun 2026	Market Purchase	7,03,28,532	Insider Trading	—	Equity Shares
12 Jun 2026	Promoter Group	Acquisition	0.038156	35.77	5.60 Cr	₹746.02	75 K	11 Jun 2026	Market Purchase	7,03,03,700	Insider Trading	—	Equity Shares
03 Jun 2026	Promoter Group	Acquisition	0.010175	35.73	1.49 Cr	₹744	20 K	29 May 2026	Market Purchase	7,02,28,700	Insider Trading	—	Equity Shares
28 May 2026	Promoter Group	Acquisition	0.039682	35.72	5.95 Cr	₹762.54	78 K	26 May 2026 - 27 May 2026	Market Purchase	7,02,08,700	Insider Trading	—	Equity Shares
25 May 2026	Promoter Group	Acquisition	0.030525	35.68	4.55 Cr	₹757.97	60 K	22 May 2026 - 25 May 2026	Market Purchase	7,01,30,700	Insider Trading	—	Equity Shares
01 Oct 2025	Promoter Group	Acquisition	0.005087	35.65	90.36 L	₹903.55	10 K	29 Sep 2025	Market Purchase	7,00,70,700	Insider Trading	—	Equity Shares
29 Sep 2025	Promoter Group	Acquisition	0.007631	0.48	1.39 Cr	₹925.37	15 K	25 Sep 2025	Market Purchase	9,41,545	Insider Trading	—	Equity Shares
29 Sep 2025	Promoter Group	Acquisition	0.002544	35.64	45.09 L	₹901.78	5 K	26 Sep 2025	Market Purchase	7,00,60,700	Insider Trading	—	Equity Shares
17 Sep 2025	Promoter Group	Acquisition	0.002645	0.47	50.04 L	₹962.23	5.20 K	15 Sep 2025	Market Purchase	9,26,545	Insider Trading	—	Equity Shares

Alembic Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Alembic Pharmaceuticals Share Price

Alembic Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Alembic Pharmaceuticals Share Price

Alembic Pharmaceuticals Share Price

Oscillators

Moving averages

Alembic Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Alembic Pharmaceuticals Share Price

Corporate Actions

Company details

Alembic Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Alembic Pharmaceuticals Share Price

News

Alembic Pharmaceuticals Establishes Dubai Based Step Down Subsidiary

Alembic Pharma Receives USFDA Approval For Ciprofloxacin Dexamethasone Suspension

Alembic Pharmaceuticals Receives USFDA Final Approval For Ciprofloxacin Otic Suspension

Alembic Pharmaceuticals schedules investor and analyst meet on September 23

Alembic Pharma receives USFDA EIR after Vadodara bioequivalence inspection

Alembic Pharmaceuticals says USFDA inspection at bioequivalence facility ended without observations

Alembic Pharmaceuticals schedules investor and analyst meets on 1st, 2nd September

Alembic Pharma targets over 15 new product launches in US by FY27

Alembic Pharma Q1 revenue rises strongly year-on-year to Rs 2150 crores

Alembic Pharma Q1 EBITDA rises YoY but margin contracts modestly

Alembic Pharma Q1 consolidated net profit rises year-on-year on steady growth

Alembic Pharma gets USFDA nod for Prucalopride tablets, boosting US pipeline

Alembic Pharmaceuticals to host Q1 FY2026 earnings call on August 4

Alembic Pharma says USFDA warning letter to investigator has no operational impact

Alembic Pharmaceuticals sees Rs 34.08 crore NSE block trade at premium price

Alembic Pharma gains USFDA final nod for Dapsone Gel, 5 percent

Alembic Pharma gets USFDA final approval for Oseltamivir oral suspension

Alembic Pharmaceuticals: Gets Tentative Approval From Usfda For Binimetinib Tablet, Which Has Us Sales Of $26.00 Crores.

Alembic Pharmaceuticals gains on getting USFDA’s final approval for Tretinoin Cream

Alembic Pharmaceuticals gets USFDA’s final approval for Tretinoin Cream

Alembic Pharmaceuticals Ltd Share Price Today

Alembic Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator